Skip to content

A Study to Evaluate White Matter Hyperintensities in Migraine

White Matter Hyperintensities in Migraine: A Multi-modal Imaging Project to Classify Disease Pathology

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05112289
Enrollment
50
Registered
2021-11-08
Start date
2021-08-16
Completion date
2026-08-31
Last updated
2025-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine, Multiple Sclerosis, Small Vessel Ischemic Disease

Brief summary

The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines

Interventions

DIAGNOSTIC_TESTBrain Neuroimaging

Non-invasive magnetic resonance imaging sequences will investigate metabolic signatures unique to migraine WMH. Imaging data will be used for development of artificial intelligence (AI) algorithms to classify the cause of WMHs.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

- Migraine (N=20): * Female only. * Ages 20-45 years. * Presence of WMH on MRI.

Exclusion criteria

* History of SVI and/or history of MS or other neurological disease other than migraine. * History of cancer or organ transplantation. * Contraindication to MRI. * Pregnancy. * History of abnormal brain MRI other than WMH. * Subjects not willing to comply with the study procedures will be removed from the study. Inclusion Criteria - SVI disease (n=10): * Female only * Ages \> 60 years. * Presence of WMH on MRI.

Design outcomes

Primary

MeasureTime frameDescription
WMH imaging disease parameters3 monthsRadiological MRI assessment of WMH in migraine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026